购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

AZD8186

产品编号 T6773Cas号 1627494-13-6

AZD8186 是 PI3K 抑制剂,能够抑制 PI3Kβ (IC5050=4 nM),PI3Kδ (IC5050=12 nM),PI3Kα (其 IC50=35 nM) 和 PI3Kγ (其 IC50=675 nM)。

AZD8186
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

AZD8186

纯度: 99.91%
产品编号 T6773Cas号 1627494-13-6

AZD8186 是 PI3K 抑制剂,能够抑制 PI3Kβ (IC5050=4 nM),PI3Kδ (IC5050=12 nM),PI3Kα (其 IC50=35 nM) 和 PI3Kγ (其 IC50=675 nM)。

规格价格库存数量
1 mg¥ 395现货
5 mg¥ 892现货
10 mg¥ 1,360现货
25 mg¥ 2,190现货
50 mg¥ 3,280现货
100 mg¥ 4,790现货
500 mg¥ 9,920现货
1 mL x 10 mM (in DMSO)¥ 981现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"AZD8186"的相关化合物库

选择批次:
纯度:99.91%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
AZD8186 is an effective and specific PI3Kβ/δ inhibitor (IC50: 4/12 nM).
靶点活性
PI3Kβ:4 nM, PI3Kδ:12 nM
体外活性
AZD8186 强效抑制对PI3Kβ抑制敏感的MDA-MB-468细胞中的p-Akt以及对PI3Kδ抑制敏感的Jeko B细胞,其IC50分别为3 nM和4 nM。[1] 在大多数PTEN缺失的细胞系中,AZD8186 显示出优先的生长抑制活性,其GI50为<1 μM。[2]
体内活性
在裸鼠体内携带PTEN缺失的PC3前列腺肿瘤异种移植物模型中,AZD8186(100 mg/kg,口服)显著抑制Akt磷酸化水平,并且显著抑制肿瘤生长。当与ABT联合使用时,AZD8186(60 mg/kg,口服)能够完全抑制肿瘤生长。[1] 在小鼠PTEN-null TNBC模型HCC70和MDA-MB-468,以及前列腺模型HID28中,AZD8186(50 mg/kg,口服)也能抑制肿瘤生长。[2] 使用AZD8186与雄激素剥夺疗法的联合治疗可导致持久的肿瘤退缩,且该效果在治疗停止后仍然持续。[3]
激酶实验
PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ enzyme assays: The inhibition of PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ human recombinant PI3K isoforms is evaluated using a Kinase-Glo Plus Assay Kit. 12 point half-log concentration-response curves with a top concentration of 100 μM are constructed by dispensing DMSO solubilised compounds into white 384-well medium-binding microplates using an Echo 555. 3 μL of the appropriate PI3K? in Tris buffer (50 mM Tris pH7.4, 0.05% CHAPS, 2.1 mM DTT, and 10 mM MgCl2) is added. The plate is covered and allowed to pre-incubate with compound for 20 minutes prior to addition of 3 μL of substrate solution containing PIP2 and ATP. The enzyme reaction is stopped after 80 minutes by the addition of Kinase Glo detection solution. Plates are covered and incubated for 30 minutes at room temperature before the luminescence signal is read using a PHERAstar plate reader. The final concentrations of DMSO, ATP and PIP2 in the assay are 2%, 8 μM, and 80 μM respectively. The final concentrations of PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ are respectively 20 nM, 20 nM, 45 nM and 30 nM. For PI3Kα, PI3Kβ and PI3Kδ the concentration of active enzyme is determined as outlined in the enzyme assay tight binding limit determination section. For PI3Kγ the concentration of enzyme is determined by Bradford assay. IC50 values are calculated using Genedata Screener.
细胞实验
Cells are seeded in 96-well plates, at a density to allow for logarithmic growth during the 72 hour assay, and incubated overnight at 37°C, 5% CO2. Cells are treated with AZD8186 (30 to 0.003 μM) for 72 hours and cell proliferation measured by MTS. The CellTiter Aqueous Non-Radioactive Cell Proliferation Assay reagent is used in accordance with the manufacturer's protocol and Absorbance measured with Tecan Ultra instrument. Pre-dose measurements are made and the concentration needed to reduce the growth of treated cells to half that of untreated cells (GI50) values are determined.(Only for Reference)
化学信息
分子量457.47
分子式C24H25F2N3O4
CAS No.1627494-13-6
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
Ethanol: 3 mg/mL (6.6 mM)
DMSO: 84 mg/mL (183.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
溶液配制表
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.1859 mL10.9297 mL21.8594 mL109.2968 mL
5 mM0.4372 mL2.1859 mL4.3719 mL21.8594 mL
DMSO
1mg5mg10mg50mg
10 mM0.2186 mL1.0930 mL2.1859 mL10.9297 mL
20 mM0.1093 mL0.5465 mL1.0930 mL5.4648 mL
50 mM0.0437 mL0.2186 mL0.4372 mL2.1859 mL
100 mM0.0219 mL0.1093 mL0.2186 mL1.0930 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy AZD8186 | purchase AZD8186 | AZD8186 cost | order AZD8186 | AZD8186 chemical structure | AZD8186 in vivo | AZD8186 in vitro | AZD8186 formula | AZD8186 molecular weight